Cargando…

Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART)

OBJECTIVE: Rates of AIDS defining event (ADE), serious ADE and death by CD4 and HIV RNA categories before and after combination antiretroviral therapy (cART) initiation are lacking for high CD4 counts. METHODS: Event rates were estimated within CD4 cell strata using a Poisson regression model adjust...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guiguet, Marguerite, Porter, Kholoud, Phillips, Andrew, Costagliola, Dominique, Babiker, Abdel
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd. 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556203/ https://www.ncbi.nlm.nih.gov/pubmed/18923700 http://dx.doi.org/10.2174/1874613600802010003

Ejemplares similares

Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV Seroconversion
por: Lodi, Sara, et al.
Publicado: (2010)

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK
por: Inshaw, Jamie, et al.
Publicado: (2015)

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

Critical Importance of Long-Term Adherence to Care in HIV Infected Patients in the cART Era: New Insights from Pneumocystis jirovecii Pneumonia Cases over 2004–2011 in the FHDH-ANRS CO4 Cohort
por: Denis, Blandine, et al.
Publicado: (2014)

Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART
por: Musinguzi, Nicholas, et al.
Publicado: (2021)

CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014)

Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Studies
por: Wolbers, Marcel, et al.
Publicado: (2010)

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
por: Touloumi, Giota, et al.
Publicado: (2013)

Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France
por: de Monteynard, Laure-Amélie, et al.
Publicado: (2015)

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV
por: Valcour, Victor G., et al.
Publicado: (2015)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
por: Bischoff, Jenny, et al.
Publicado: (2021)

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration
por: Olson, Ashley D., et al.
Publicado: (2014)

Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients
por: Chow, Wei Zhen, et al.
Publicado: (2015)

Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition
por: Mossdorf, Erik, et al.
Publicado: (2011)

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4(+) T-cell recovery once HIV-1 suppression is achieved?
por: Jarrin, Inma, et al.
Publicado: (2015)

Effect of once-daily FDC treatment era on initiation of cART
por: Mosen, David M, et al.
Publicado: (2010)

Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults
por: Mathiesen, Inger Hee, et al.
Publicado: (2017)

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
por: Hattab, Suhaib, et al.
Publicado: (2014)

Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection
por: Lodi, Sara, et al.
Publicado: (2013)

Combination antiretroviral therapy (cART)-induced hippocampal disorders: Highlights on therapeutic potential of Naringenin and Quercetin
por: Akang, Edidiong N., et al.
Publicado: (2019)

Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV
por: Spitsin, Sergei, et al.
Publicado: (2021)

Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell count
por: Ji, Yongjia, et al.
Publicado: (2018)

Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients
por: Depincé-Berger, Anne-Emmanuelle, et al.
Publicado: (2016)

AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)

Improved induced innate immune response after cART initiation in people with HIV
por: Hove-Skovsgaard, Malene, et al.
Publicado: (2022)

Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era
por: Álvaro-Meca, Alejandro, et al.
Publicado: (2016)

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
por: Salido, Jimena, et al.
Publicado: (2021)

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression
por: Restrepo, Clara, et al.
Publicado: (2019)

Attitudes and beliefs towards early ART initiation in MSM with primary HIV infection
por: Parsons, Victoria, et al.
Publicado: (2014)

Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway
por: Liu, Man-Qing, et al.
Publicado: (2017)

Interactions of alcohol and combination antiretroviral (cART) drug in diabetic male Sprague Dawley rats: Hippocampal perturbations and toxicosis
por: Asouzu Johnson, Jaclyn, et al.
Publicado: (2023)

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
por: Krastinova, Evguenia, et al.
Publicado: (2015)

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
por: Dold, Leona, et al.
Publicado: (2017)

Adherence to combined Antiretroviral therapy (cART) among people living with HIV/AIDS in a Tertiary Hospital in Ilorin, Nigeria
por: Anyaike, Chukwuma, et al.
Publicado: (2019)

Liberation from Dialysis Dependence in a Patient with HIV-Associated Nephropathy (HIVAN) after Combined Antiretroviral Therapy (cART)
por: Ramoutar, Virin, et al.
Publicado: (2020)

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
por: Pantazis, Nikos, et al.
Publicado: (2016)

Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen
por: Aragão, F, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mk537jr0sdgau4e9ek522rlq1i